Heart, Vascular & Thoracic Institute (Miller Family) Outcomes
Valve Disease
Transcatheter Aortic Valve Replacement
Transcatheter Aortic Valve Replacement: Volume and In-Hospital Mortality
2017 – 2021
Since the start of the transcatheter aortic valve replacement (TAVR) program in 2006, Cleveland Clinic consistently achieves better-than-expected outcomes.
The in-hospital mortality rates for patients who had TAVR at Cleveland Clinic remain lower than the expected rate. Calculated observed to expected ratios remain less than the value of 1 indicating that Cleveland Clinic mortality is better than expected in these procedures.
| Year | O:E (observed to expected mortality ratio) |
|---|---|
| 2017 | 0.1 |
| 2018 | 0.1 |
| 2019 | 0.0 |
| 2020 | 0.1 |
| 2021 | 0.6 |
Source: Data from the Vizient Clinical Data Base used with permission of Vizient, Inc. All rights reserved.
Source for mortality rates and volume: Society of Thoracic Surgeons (STS) National Adult Cardiac Surgery Database.
Transcatheter Aortic Valve Replacement: Volume by Approach
2021, N = 652
The majority of transcatheter aortic valve replacement (TAVR) procedures done at Cleveland Clinic involve a transfemoral approach. This approach was used in 96% of the 652 TAVR procedures performed in 2021.
Source: Society of Thoracic Surgeons (STS) National Adult Cardiac Surgery Database
The total TAVR procedures reported were done by a team of cardiothoracic surgeons and interventional cardiologists.
